Day: November 14, 2023

SAN DIEGO, CA, Nov. 14, 2023 (GLOBE NEWSWIRE) — via NewMediaWire –Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announces financial results for the third quarter ended September 30, 2023. During the quarter, the Company continued its plan to initiate first-in-human studies of Sigyn TherapyTM and further advanced its endeavors to develop pipeline technologies to enhance the performance of cancer therapies. The initial treatment indication of Sigyn TherapyTM is being directed toward end-stage renal disease (ESRD) patients with endotoxemia, a condition that is highly prevalent and associated with increased mortality in the ESRD population.  The Company has identified three clinical site locations and is working with principal investigators to finalize the study...

Revenue of $66.2 million for Q3 2023 and $225.6 million for YTD 2023 Gross profit (exclusive of depreciation and amortization) of $16.1 million for Q3 2023 and $57.7 million for YTD 2023 Net loss of $33.6 million for Q3 2023 and $61.3 million for YTD 2023 Media margin of $19.3 million for Q3 2023 and $67.2 million for YTD 2023 Adjusted EBITDA of negative $1.7 million for Q3 2023 and positive $4.3 million for YTD 2023 Adjusted net loss of $4.1 million for Q3 2023 and $6.8 million for YTD 2023NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) — Fluent, Inc. (NASDAQ: FLNT), a leading data-driven performance marketing company, today reported financial results for the third quarter ended September 30, 2023. Don Patrick, Fluent’s Chief Executive Officer, commented, “Our third quarter results clearly reflect our post-FTC settlement transition...

Reports Eleventh Consecutive Quarter of Positive Adjusted EBITDA The Botanist Danbury Dispensary in Connecticut Achieves Highest Company-wide Sales with 64% Year-Over-Year Growth Delivered record wholesale sales in New Jersey with the Company’s large-scale infrastructure project at the Egg Harbor Township, NJ facility nearing completion   NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), a vertically integrated, multi-state operator of cannabis cultivation and retailing facilities in the U.S., today reported its financial results for the third quarter ended September 30, 2023 (“Q3 2023”). Third Quarter 2023 Financial HighlightsConsolidated revenue of $56.5 million, a decrease of 2.8% compared to the quarter ended June 30, 2023 (“Q2 2023”). Gross...

LONGVIEW, Texas, Nov. 14, 2023 (GLOBE NEWSWIRE) — Friedman Industries, Incorporated (NYSE American: FRD) announced today its results of operations for the quarter ended September 30, 2023. September 30, 2023 Quarter Highlights:Net earnings of approximately $3.5 million Sales of approximately $130.7 million 10% increase in sales volume over prior year quarter volume Working capital balance at quarter-end of approximately $129.9 million“Our second quarter results are a testament to our team’s ability to evaluate challenging market conditions and make the appropriate decisions to deliver increased sales volume and profitable results in periods of significant headwinds to profitability,” said Michael J. Taylor, President and Chief Executive Officer. “We experienced a significant decline in steel prices entering the second quarter...

TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) — Nexus Industrial REIT (the “REIT”) (TSX: NXR.UN) announced today its results for the quarter ended September 30, 2023. HighlightsNovember 1 – acquired a 336,448 square foot industrial property located in London, Ontario for $55.8 million with $27.1 million of the purchase price being settled in units valued at $11.30 per unit. September 12 – increased the REIT’s unsecured credit facilities from $375 million to $525 million. July 4 – acquired a 141,534 square foot industrial property located in Burlington, Ontario for $48.4 million. NOI from industrial properties anticipated to be approximately 91% for Q4 as a result of these transactions. Occupancy of 97% at September 30, 2023 was consistent with 97% at June 30, 2023 and September 30, 2022. Q3 2023 net operating income of $29.3 million...

Advancing Discussions with Potential Strategic Partners Received Frost & Sullivan’s 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award Closed $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules; Extends Cash Runway into Q4 2024 CHARLOTTESVILLE, Va., Nov. 14, 2023 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the third quarter of 2023. Cary Claiborne, President and Chief Executive Officer of Adial, stated, “We have made steady progress throughout the third quarter of 2023 including receiving favorable...

TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) — Clairvest Group Inc. (TSX: CVG) today reported results for the fiscal 2024 second quarter and six months ended September 30, 2023. (All figures are in Canadian dollars unless otherwise stated) HighlightsSeptember 30, 2023 book value was $1,181.0 million or $78.61 per share compared with $1,225.0 million or $81.54 per share as at June 30, 2023 Net loss for the quarter ended September 30, 2023 was $44.0 million or $2.93 per share Net loss for the six months ended September 30, 2023 was $24.5 million or $1.63 per share Clairvest and Clairvest Equity Partners VI (“CEP VI”) made an equity investment in Mountain Land Physical Therapy (“Mountain Land PT”) Clairvest and CEP VI invested in NexTech Solutions (“NexTech”) Clairvest and CEP VI completed the sale of Arrowhead Environmental Partners...